HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard Prentice Selected Research

sulfoxide

10/2014Mode of action of S-methyl-N, N-diethylthiocarbamate sulfoxide (DETC-MeSO) as a novel therapy for stroke in a rat model.
1/2013Taurine exerts robust protection against hypoxia and oxygen/glucose deprivation in human neuroblastoma cell culture.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard Prentice Research Topics

Disease

14Stroke (Strokes)
10/2020 - 08/2012
6Hypoxia (Hypoxemia)
01/2017 - 03/2002
4Infarction (Infarctions)
01/2018 - 01/2013
4Ischemic Stroke
01/2018 - 06/2013
4Ischemia
01/2017 - 01/2013
3Brain Ischemia (Cerebral Ischemia)
01/2020 - 01/2017
3Nervous System Diseases (Neurological Disorders)
01/2018 - 01/2013
3Brain Injuries (Brain Injury)
01/2017 - 01/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 01/2015
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2017 - 10/2014
2Mitochondrial Diseases (Mitochondrial Disease)
01/2015 - 01/2013
2Huntington Disease (Huntington's Disease)
01/2014 - 01/2013
2Alzheimer Disease (Alzheimer's Disease)
01/2014 - 01/2013
1Body Weight (Weight, Body)
01/2018
1Inflammation (Inflammations)
07/2017
1Macular Degeneration (Age-Related Maculopathy)
11/2014
1Reperfusion Injury
11/2014
1Gliosis
10/2014
1Brain Infarction
10/2014
1Central Nervous System Diseases (CNS Diseases)
01/2014
1Parkinson Disease (Parkinson's Disease)
01/2014
1Neuroblastoma
01/2013
1Neoplasms (Cancer)
11/2009
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2009
1Necrosis
03/2002

Drug/Important Bio-Agent (IBA)

9TaurineFDA Link
07/2017 - 08/2012
6Sulindac (Copal)FDA LinkGeneric
01/2017 - 11/2009
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2020 - 01/2013
4Glutamic Acid (Glutamate)FDA Link
01/2017 - 08/2012
3Neuroprotective AgentsIBA
01/2017 - 01/2013
3Pharmaceutical PreparationsIBA
01/2017 - 11/2009
3S-methyl N,N-diethylthiolcarbamate sulfoxideIBA
01/2017 - 01/2013
2Proteins (Proteins, Gene)FDA Link
07/2017 - 01/2013
2Caspase 12IBA
01/2017 - 08/2012
2Amino AcidsFDA Link
01/2017 - 01/2017
2CalciumIBA
01/2015 - 01/2013
2sulfoxideIBA
10/2014 - 01/2013
1LigandsIBA
01/2020
1Apoptosis Regulatory ProteinsIBA
01/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1CationsIBA
07/2017
1N-Methylaspartate (NMDA)IBA
01/2017
1Endoplasmic Reticulum Chaperone BiPIBA
01/2017
1CalpainIBA
01/2015
1gamma-Aminobutyric Acid (GABA)IBA
01/2015
1EnzymesIBA
01/2015
1Retinaldehyde (Retinal)IBA
11/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2014
1Phosphotransferases (Kinase)IBA
08/2014
1Molecular Chaperones (Chaperone, Molecular)IBA
08/2014
1Adenosine Triphosphate (ATP)IBA
01/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1Caspase 3 (Caspase-3)IBA
01/2013
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2013
1AntioxidantsIBA
01/2013
1Oxygen (Dioxygen)IBA
01/2013
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2009
1SB 203580IBA
03/2002
1p38 Mitogen-Activated Protein KinasesIBA
03/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2002
1JNK Mitogen-Activated Protein KinasesIBA
03/2002

Therapy/Procedure

5Therapeutics
10/2020 - 10/2014
1Injections
08/2014